Related Experiment Video
Updated: Jan 21, 2026

Author Spotlight: Hickman Catheter Use for Long-Term Vascular Access in a Preclinical Swine Model
Published on: March 31, 2023
Effect of coexisting vascular disease on long-term risk of recurrent events after TIA or stroke
Marion Boulanger1, Linxin Li1, Shane Lyons1
1From the Centre for Prevention of Stroke and Dementia (M.B., L.L., S.L., N.G.L., M.M.K., L.S., P.M.R.), Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, UK; and Service de Neurologie (M.B., E.T.), CHU Caen Normandie, UNICAEN, Normandie Université, INSERM U1237, Caen, France.
Insights
Patients with transient ischemic attack (TIA) or ischemic stroke and existing cardiovascular disease face a high risk of recurrent events. Current guidelines may not be sufficient, suggesting a need for more intensive lipid-lowering strategies.
Area of Science:
- Neurology
- Cardiology
- Vascular Medicine
Background:
- Secondary prevention guidelines aim to reduce recurrent ischemic events after TIA or stroke.
- Coexisting cardiovascular disease (CVD) may impact the effectiveness of current secondary prevention strategies.
Purpose of the Study:
- To assess the risk of recurrent ischemic events in patients with TIA or ischemic stroke who also have existing cardiovascular disease.
- To evaluate if current secondary prevention guidelines adequately manage these high-risk patients.
Main Methods:
- A population-based study (Oxford Vascular Study) in the UK from 2002-2014.
- Consecutive patients with TIA or ischemic stroke were followed, with treatment adhering to current guidelines.
- Risk stratification was performed based on the presence of coexisting cardiovascular disease (coronary or peripheral artery disease).
Main Results:
- Patients with TIA/stroke and coexisting CVD had a significantly higher 10-year risk of coronary events (22.8% vs. 7.1%) and recurrent ischemic stroke (31.5% vs. 23.4%).
- These increased risks persisted despite similar medication use (antithrombotics, lipid-lowering) compared to patients without CVD.
- A higher risk of extracranial bleeds was observed in patients with noncardioembolic TIA/stroke and coexisting CVD, particularly those under 75 years.
Conclusions:
- Patients with TIA/stroke and coexisting cardiovascular disease remain at high risk for recurrent ischemic events, even with current management protocols.
- More aggressive lipid-lowering therapy may be warranted.
- Increased antithrombotic treatment benefits could be negated by a higher risk of extracranial bleeding.
Objective:
To determine whether patients with TIA or ischemic stroke with coexisting cardiovascular disease (i.e., history of coronary or peripheral artery disease) are still at high risk of recurrent ischemic events despite current secondary prevention guidelines.
Methods:
In a population-based study in Oxfordshire, UK (Oxford Vascular Study), we studied consecutive patients with TIA or ischemic stroke for 2002-2014. Patients were treated according to current secondary prevention guidelines and we determined risks of coronary events, recurrent ischemic stroke, and major bleeding stratified by the presence of coexisting cardiovascular disease.
Results:
Among 2,555 patients (9,148 patient-years of follow-up), those (n = 640; 25.0%) with coexisting cardiovascular disease (449 coronary only; 103 peripheral only; 88 both) were at higher 10-year risk of coronary events than those without (22.8%, 95% confidence interval 17.4-27.9; vs 7.1%, 5.3-8.8; p < 0.001; age- and sex-adjusted hazard ratio [HR] 3.07, 2.24-4.21) and of recurrent ischemic stroke (31.5%, 25.1-37.4; vs 23.4%, 20.5-26.2; p = 0.0049; age- and sex-adjusted HR 1.23, 0.99-1.53), despite similar rates of use of antithrombotic and lipid-lowering medication. However, in patients with noncardioembolic TIA/stroke, risk of extracranial bleeds was also higher in those with coexisting cardiovascular disease, particularly in patients aged <75 years (8.1%, 2.8-13.0; vs 3.4%, 1.6-5.3; p = 0.0050; age- and sex-adjusted HR 2.71, 1.16-6.30), although risk of intracerebral hemorrhage was not increased (age- and sex-adjusted HR 0.36, 0.04-2.99).
Conclusions:
As in older studies, patients with TIA/stroke with coexisting cardiovascular disease remain at high risk of recurrent ischemic events despite current management. More intensive lipid-lowering might therefore be justified, but benefit from increased antithrombotic treatment might be offset by the higher risk of extracranial bleeding.
Related Concept Videos
Relative Risk
Long-term Depression
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Seedless Vascular Plants
Integration of Synaptic Events
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

